Ilić N, Atkinson K. Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: Establishment and evaluation of a protocol. Vojnosanit Pregl [Internet]. 2014 Jun. 30 [cited 2026 Jul. 12];71(7). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/VSP130410050I